Informazioni sul prodotto
- 1-Pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-
- Amacetam
- N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
- N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide sulfate (1:1)
- N-[2-[Bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide
- Vinpotropil
Pramiracetam is a nootropic drug that is used to treat symptoms of dementia and other cognitive disorders. It has pharmacological effects on the brain by interacting with the fatty acid composition of cell membranes, which affects voltage-dependent calcium channels. Pramiracetam also increases cholinergic neurotransmission and increases energy metabolism in cells by increasing adenosine triphosphate (ATP) synthesis. This drug's pharmacokinetic properties include a high bioavailability, rapid absorption, and short half-life. Histological analysis of animals treated with pramiracetam has shown an increase in the size of neurons and synapses in the cerebral cortex, hippocampus, olfactory bulb, cerebellum, and hypothalamus.
Proprietà chimiche
Richiesta tecnica su: 3D-FP35140 Pramiracetam
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
